Skip to content
Open in App
Madrigal Pharma logo

Madrigal Pharma

web2

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therap...

Symbol · 1MDGL
Company profile

About

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeNasdaqPrimary symbol: 1MDGL
ExchangeMilanPrimary symbol: 1MDGL
Expert coverage

1 expert evaluated Madrigal Pharma.

Orbitrum research

Experts evaluating Madrigal Pharma

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment